title: [Differentiated thyroid carcinoma: initial evaluation and follow-up].
abstract: Thyroid carcinoma accounts for roughly 1% of all new malignant diseases. Of these, at least 94% are differentiated thyroid carcinoma (DTC), either papillary thyroid carcinoma or follicular thyroid carcinoma. Patients with DTC are usually considered as having a good prognosis, 80% of patients are cured, 20% will develop loco-regional recurrence and 5-10% distant metastasis. However, the disease may have an aggressive course in some patients. The identification of these patients has a major impact in the clinical management of DTC. Several prognostic factors and classification will be addressed, as well the most useful tests for patients follow-up.
authors.affiliation: Serviço de Endocrinologia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS.
authors.forename: Lenara
authors.initials: L
authors.lastname: Golbert
authors.forename: Simone Magagnin
authors.initials: SM
authors.lastname: Wajner
authors.forename: Andreia Possatti da
authors.initials: AP
authors.lastname: Rocha
authors.forename: Ana Luiza
authors.initials: AL
authors.lastname: Maia
authors.forename: Jorge Luiz
authors.initials: JL
authors.lastname: Gross
mesh_terms: D018263:Adenocarcinoma, Follicular / Q000175:diagnosis / Q000556:secondary / Q000628:therapy; D002291:Carcinoma, Papillary / Q000175:diagnosis / Q000556:secondary / Q000628:therapy; D005500:Follow-Up Studies; D006801:Humans; D009361:Neoplasm Invasiveness; D009363:Neoplasm Proteins / Q000097:blood; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D009367:Neoplasm Staging; D011379:Prognosis; D013954:Thyroglobulin / Q000097:blood; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy
chemical_list: D009363:Neoplasm Proteins; D013954:Thyroglobulin